Stuart W. Peltz

2020

In 2020, Stuart W. Peltz earned a total compensation of $10.6M as Chief Executive Officer at PTC Therapeutics, a 36% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$835,300
Option Awards$7,163,426
Salary$742,000
Stock Awards$1,688,280
Other$123,786
Total$10,552,792

Peltz received $7.2M in option awards, accounting for 68% of the total pay in 2020.

Peltz also received $835.3K in non-equity incentive plan, $742K in salary, $1.7M in stock awards and $123.8K in other compensation.

Rankings

In 2020, Stuart W. Peltz's compensation ranked 770th out of 13,090 executives tracked by ExecPay. In other words, Peltz earned more than 94.1% of executives.

ClassificationRankingPercentile
All
770
out of 13,090
94th
Division
Manufacturing
267
out of 5,617
95th
Major group
Chemicals And Allied Products
85
out of 2,248
96th
Industry group
Drugs
74
out of 1,948
96th
Industry
Pharmaceutical Preparations
57
out of 1,453
96th
Source: SEC filing on April 29, 2021.

Peltz's colleagues

We found five more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2020.

2020

Marcio Souza

PTC Therapeutics

Chief Operating Officer

2020

Eric Pauwels

PTC Therapeutics

Chief Business Officer

2020

Neil Almstead

PTC Therapeutics

Chief Technical Operations Officer

2020

Emily Hill

PTC Therapeutics

Chief Financial Officer

2020

Mark Boulding

PTC Therapeutics

Chief Legal Officer

News

In-depth

You may also like